文献速递免疫规划

母体抗体与预存抗体对灭活轮状病毒疫苗免疫原性的影响

Impact of maternal and pre-existing antibodies on immunogenicity of inactivated rotavirus vaccines.
PubMed 文献 · Vaccine · 2022-05-27

研究从重症腹泻婴儿粪便中分离的野生型人轮状病毒株ZTR-68-A(G1P[8])制备灭活轮状病毒疫苗(IRV),在新生BALB/c小鼠中评估母体抗体和预存抗体对IRV免疫原性的影响。结果显示,疫苗免疫或轮状病毒感染产生的母体抗体对两剂IRV接种的免疫应答有部分影响;增加免疫次数可显著提高血清中和抗体滴度,血清阳转率可达100%。新生小鼠单次病毒感染未产生可检测的血清中和抗体,接种IRV后免疫应答未受影响,滴度与对照组小鼠相比无显著差异。

要点

  • 母体抗体(疫苗免疫或轮状病毒感染产生)对两剂IRV接种的免疫应答有部分影响。
  • 增加免疫次数可显著提高血清中和抗体滴度,血清阳转率可达100%。
  • 新生小鼠单次病毒感染未产生可检测的血清中和抗体,接种IRV后免疫应答未受影响。

核心结论

  • 选择合适的免疫剂量和接种频率对IRV的免疫效果至关重要。
  • 本研究结果为未来IRV临床研究提供动物实验支持。

研究设计与样本

  • 在新生BALB/c小鼠中评估母体抗体和预存抗体对IRV免疫原性的影响。
  • IRV由从重症腹泻婴儿粪便中分离的野生型人轮状病毒株ZTR-68-A(G1P[8])制备。

主要发现

  • 疫苗免疫或轮状病毒感染产生的母体抗体对两剂IRV接种的免疫应答有部分影响。
  • 增加免疫次数可显著提高血清中和抗体滴度,血清阳转率可达100%。
  • 新生小鼠单次病毒感染未产生可检测的血清中和抗体,接种IRV后免疫应答未受影响,滴度与对照组小鼠相比无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rotavirus (RV) is a major pathogen causing severe diarrhea in infants and children aged less than 5 years. Vaccination is an economically feasible and effective strategy to prevent rotavirus infections. However, immune efficacy of live vaccines could be interfered by maternal antibodies and pre-existing antibodies of children. To develop an inactivated rotavirus vaccine (IRV), we had previously isolated a wild-type human rotavirus strain ZTR-68-A (G1P[8]) from the fecal samples of infants having severe diarrhea in a region endemic for the presence of this pathogen. In our present study, we assessed whether the presence of maternal and pre-existing antibodies in newborn BALB/c mice affected the immunogenicity of IRV administered to these animals. Our results indicate that maternal antibodies, generated from either vaccine immunization or rotavirus infection, showed partial influence with the immune responses generated by two doses of IRV vaccination. Increasing the number of immunizations can significantly improve the titer of serum neutralizing antibody and a seroconversion rate of up to 100%. In newborn mice, single-virus infection did not elicit detectable levels of serum neutralizing antibodies. After an IRV vaccination, the immune responses of these mice remained unaffected, with no significant differences in titers compared with those of control-group mice. In summary, choosing a suitable immunization dose and dosing frequency is essential for the immune effectiveness of IRV. The results of this study will provide animal experimental support for the IRV clinical research in future.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zhou Y, Hu X, Chen R, et al. Impact of maternal and pre-existing antibodies on immunogenicity of inactivated rotavirus vaccines. Vaccine. 2022. PMID: 35644669. doi:10.1016/j.vaccine.2022.05.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。